Bioquell announces Michael Roller as upcoming new Group Finance Director

Bioquell PLC (“Bioquell”) (LSE symbol: BQE) – provider of specialist microbiological control technologies to the international Healthcare, Life Sciences & Defence markets; and specialist testing services in the UK via its TRaC division, today announces that it has appointed Michael Roller (ACA) to be its new Group Finance Director.

Mr Roller has previously been Finance Director of a number of quoted companies, most recently Corin Group plc, has significant experience within the Life Sciences sector and is a non-executive director of Filtronic plc. He has also held a number of other senior finance roles in a broad range of listed and private companies. He qualified as an accountant with KPMG.

Michael Roller will start work with the Group on 10 February 2014 and will formally assume the role of Group Finance Director on 18 March, following the announcement of the Group’s preliminary results for the year ended 31 December 2013.

Commenting on the recruitment of Michael Roller as Group Finance Director, Nigel Keen, Bioquell’s Chairman, said: “We are delighted that Michael has agreed to join Bioquell as Finance Director. He has extensive and highly relevant experience – and we look forward to his contribution to the next stage in the growth of the Group.”

- DisclaimerNews, data and statement included in this release are intended exclusively for general information purposes. Talent4Boards accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the adequacy or accuracy of the information. No data or statement in this release should be considered for decisions about securities referred. Product and brand names used in this release maybe trademarks or registered trademarks of their respective owners.

Comments are closed.

Warning: file_get_contents( failed to open stream: HTTP request failed! HTTP/1.1 404 Not Found in /var/sites/t/ : runtime-created function on line 1